DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly dividend of 40 cents per share, an increase of 6.7 percent over the year-ago period. The dividend is payable 12 March 2018 to stockholders of record as of 15

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the first quarter of fiscal 2018 which ended 30 November 2017.

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today that Executive Vice Chairman and CEO Stefano Pessina and Co-Chief Operating Officer Alex Gourlay will participate in a fireside chat at the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announces that it has entered into an agreement to reduce its stake in Guangzhou Pharmaceuticals Corporation, a pharmaceutical wholesaling joint venture in China, following an offer from its joint venture partner Guangzhou

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announces that it has reached an agreement with China National Accord Medicines Corporation Ltd. to become an investor in its subsidiary Sinopharm Holding Guoda Drugstores Co., Ltd. (“GuoDa”), which operates and franchises retail

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today that Co-Chief Operating Officer Alex Gourlay will participate in a fireside chat at the Credit Suisse 26th Annual Healthcare Conference at The Phoenician, Scottsdale, Ariz. on Tuesday, 7 November at 8:00 a.m. Mountain time

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the fourth quarter and fiscal year 2017, which ended 31 August 2017.